KERN · Akerna Corp

Akerna Corp is currently in a long term downtrend where the price is trading 15.4% below its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.

Akerna Corp's total revenue rose by 24.3% to $4M since the same quarter in the previous year.

Its net income has dropped by 181.6% to $-12M since the same quarter in the previous year.

Finally, its free cash flow fell by 39.1% to $-5M since the same quarter in the previous year.

Based on the above factors, Akerna Corp gets an overall score of 2/5.